Zainul Charbiwala rapidly shuffles through papers in his conference room on a Monday afternoon. The chief technology officer of Tricog Health Services Pvt. Ltd—one of the biggest Indian startups offering electrocardiogram, or ECG, services—has back-to-back meetings. Time is in short supply.

He glances every now and then at his Apple Watch—an action not without a tinge of irony for the co-founder of a portable-ECG company.

The latest model of the smartwatch has made waves around the world for a very specific feature: an ECG app that can monitor your heart rate and detect irregular rhythms. News reports abound of how the Apple Watch has “saved” iPhone users’ lives in the US and Germany since the ECG feature was launched in December. (In fact, in the last week of April, the US Food and Drug Administration (FDA) also cleared an iPhone accessory that can conduct more complex ECGs than the Apple Watch’s basic sensor.)

ECG tech—a fundamental diagnostic tool for cardiac care—has seen rapid evolution in recent years. From bulky hospital units to portable yet conventional devices to miniature patches and wearables to AI-enabled services.

In India in particular, the past five years or so have seen a slew of ECG startups mushroom across the country. All hoping to make a dent in an untapped market—while an ECG is a basic service for a large private hospital, most primary care facilities in India are not equipped with ECG machines on account of cost and complexity. At the same time, the country has one of the highest burdens of cardiac disease in the world.

In 2016, 5,681 in every 100,000 Indians suffered from cardiovascular disease—54.6 million in total, according to a study published in the Journal of the American College of Cardiology. The death rate jumped 34% between 1990 and 2016 to about 2.8 million deaths a year.

The likelihood of surviving a heart attack is over 80%, if action is taken within the first two hours. “However, the average time between symptoms and treatment in India is over six hours,” says Charit Bhograj, an interventional cardiologist and Tricog co-founder. Which is where access to ECGs comes into play—an electrocardiogram measures heart function and is the first step to diagnose cardiac conditions.

When companies like Tricog entered the market to solve the problem of access through remote diagnostic services, the assumption was they’d build a service network away from the traditional hospital system. With inexpensive portable devices, some training and intelligent algorithms, a caregiver in smaller towns could diagnose, cut costs and save millions of lives every year. The assumption was also that like fintech, which complements banking today, ECG as a service would meet the burgeoning demand and improve cardiac care quality at the same time.


Suraksha P

Suraksha writes on Healthcare and Pharma. She has been a journalist for five years, reporting for The New Indian Express in Bengaluru and Chennai, and The Times of India, Delhi. In her previous stints she has written on health, civic issues and education. She investigated cover up of corruption in the state health department’s think tank, narrated harrowing tales of women who underwent unwarranted hysterectomies, and wrote about how loss of biometrics came in the way of Leprosy patients getting an Aadhaar card and thereby pension. She can be reached at suraksha at the-ken dot com.

View Full Profile

Available exclusively to subscribers of The Ken India

This story is a part of The Ken India edition. Subscribe. Questions?


Annual Subscription

12-month access to 200+ stories, archive of 800+ stories from our India edition. Plus our premium newsletters, Beyond The First Order and The Nutgraf worth Rs. 99/month or $2/month each for free.

Rs. 2,750


Quarterly Subscription

3-month access to 60+ new stories with 3-months worth of archives from our India edition. Plus our premium newsletters, Beyond The First Order and The Nutgraf worth Rs. 99/month or $2/month each for free.

Rs. 1,750


Single Story

Instant access to this story for a year along with comment privileges.

Rs. 500


Annual Subscription

12-month access to 150+ stories from Southeast Asia.

$ 120


Quarterly Subscription

3-month access to 35+ stories from Southeast Asia.

$ 50


Single Story

Instant access to this story for a year along with comment privileges.

$ 20



What is The Ken?

The Ken is a subscription-only business journalism website and app that provides coverage across two editions - India and Southeast Asia.

What kind of stories do you write?

We publish sharp, original and reported stories on technology, business and healthcare. Our stories are forward-looking, analytical and directional — supported by data, visualisations and infographics.

We use language and narrative that is accessible to even lay readers. And we optimise for quality over quantity, every single time.

What do I get if I subscribe?

For subscribers of the India edition, we publish a new story every weekday, a premium daily newsletter, Beyond The First Order and a weekly newsletter - The Nutgraf.

For subscribers of the Southeast Asia edition, we publish a new story three days a week and a weekly newsletter, Strait Up.

The annual subscription will get you complete, exclusive access to our archive of previously published stories for your edition, along with access to our subscriber-only mobile apps, our premium comment sections, our newsletter archives and several other gifts and benefits.

Do I need to pay separately for your premium newsletters?

Nope. Paid, premium subscribers of The Ken get our newsletters delivered for free.

Does a subscription to the India edition grant me access to Southeast Asia stories? Or vice-versa?

Afraid not. Each edition is separate with its own subscription plan. The India edition publishes stories focused on India. The Southeast Asia edition is focused on Southeast Asia. We may occasionally cross-publish stories from one edition to the other.

Do you offer an all-access joint subscription for both editions?

Not yet. If you’d like to access both editions, you’ll have to purchase two subscriptions separately - one for India and the other for Southeast Asia.

Do you offer any discounts?

No. We have a zero discounts policy.

Is there a free trial I can opt for?

We don’t offer any trials, but you can sign up for a free account which will give you access to the weekly free story, our archive of free stories and summaries of the paid stories. You can stay on the free account as long as you’d like.

Do you offer refunds?

We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am facing some trouble purchasing a subscription. What can I do?

Please write to us at [email protected] detailing the error or queries.